Mark Brady

MCP-1 but not CINC synthesis is increased in rat pancreatic acini in response to cerulein hyperstimulation.

Energy recovery from New York City municipal solid wastes.

Expression of the chemokines MCP-1/JE and cytokine-induced neutrophil chemoattractant in early acute pancreatitis.

Nitrogen in the Baltic Sea--policy implications of stock effects.

Pilot evaluation of high-dose carboplatin and paclitaxel followed by high-dose melphalan supported by peripheral blood stem cells in previously untreated advanced ovarian cancer: a gynecologic oncology group study.

Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study.

Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development.

Large-scale mapping and predictive modeling of submerged aquatic vegetation in a shallow eutrophic lake.

Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study.

Bootstrapped learning of novel objects.

Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study.

The ethics of reporting and disseminating results of clinical research trials.

Analysis of CHEK2 gene for ovarian cancer susceptibility.

Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.

Secondary surgical cytoreduction for advanced ovarian carcinoma.

Regulation of p53 and MDM2 activity by MTBP.

p53 regulation and function in renal cell carcinoma.

Pretreatment CA-125 and risk of relapse in advanced ovarian cancer.

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.

Intraperitoneal therapy for ovarian cancer: a treatment ready for prime time.

Survey of orthopaedic and sports medicine physicians regarding use of medrol dosepak for sports injuries.

Effects of initial graft tension on the tibiofemoral compressive forces and joint position after anterior cruciate ligament reconstruction.

Any given Sunday. Paramedics assist trainers and physicians in the NFL's largest stadium.

Directly observed highly active antiretroviral therapy for HIV-infected children in Cambodia.

An early signal of CA-125 progression for ovarian cancer patients receiving maintenance treatment after complete clinical response to primary therapy.

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.

Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group Study.

Corticosteroids reduce postoperative morbidity after third molar surgery: a systematic review and meta-analysis.

Speeding up the evaluation of new agents in cancer.

Tibiofemoral compression force differences using laxity- and force-based initial graft tensioning techniques in the anterior cruciate ligament-reconstructed cadaveric knee.

Camera calibration for natural image studies and vision research.

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.

Survival after second-line intraperitoneal therapy for the treatment of epithelial ovarian cancer: the Gynecologic Oncology Group experience.

Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia.

Aciclovir neurotoxicity is an important side effect of therapy in patients with renal impairment.

Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons.

The role of primary care in managing chronic kidney disease.

Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer.

Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study.

Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study.

EORTC 55971: does it apply to all patients with advanced state ovarian cancer?

Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.

Nuclear P27 expression in benign, borderline (LMP) and invasive tumors of the ovary and its association with prognosis: a gynecologic oncology group study.

Back to the future: changes in the dialysis delivery model in the UK.

A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group Study.

Clinical trials in recurrent ovarian cancer.

CA125 regression in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy: A gynecologic oncology group study.

Macrophage reactivity to different polymers demonstrates particle size- and material-specific reactivity: PEEK-OPTIMA(®) particles versus UHMWPE particles in the submicron, micron, and 10 micron size ranges.

Incorporation of bevacizumab in the primary treatment of ovarian cancer.

Object recognition in clutter: cortical responses depend on the type of learning.

How to design a targeted agricultural subsidy system: efficiency or equity?

Cytokine use and survival in the first-line treatment of ovarian cancer: A Gynecologic Oncology Group Study.